 | Up a level |
Popp, Albrecht; Varathan, Nadshathra; Buffat, Helene; Senn, Christoph; Perrelet, Romain; Lippuner, Kurt (2018). Bone Mineral Density Changes After 1 Year of Denosumab Discontinuation in Postmenopausal Women with Long-Term Denosumab Treatment for Osteoporosis. Calcified tissue international, 103(1), pp. 50-54. Springer 10.1007/s00223-018-0394-4
Popp, Albrecht; Senn, R; Curkovic, Ivanka Monika; Senn, Christoph; Buffat, Helene; Popp, P F; Lippuner, Kurt (2017). Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate. Osteoporosis international, 28(6), pp. 1995-2002. Springer 10.1007/s00198-017-3992-5
Senn, Christoph; Günther, Beatrice; Popp, Albrecht; Perrelet, Romain; Hans, D; Lippuner, Kurt (2014). Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study. Osteoporosis international, 25(7), pp. 1945-1951. Springer 10.1007/s00198-014-2703-8
Popp, Albrecht W.; Buffat, Helena; Cavelti, Ariane; Windolf, M.; Perrelet, R.; Senn, Christoph; Lippuner, Kurt (2014). Cortical bone loss at the tibia in postmenopausal women with osteoporosis is associated with incident non-vertebral fractures: Results of a randomized controlled ancillary study of HORIZON. Maturitas, 77(3), pp. 287-293. Elsevier 10.1016/j.maturitas.2013.12.013
Popp, Albrecht W.; Guler, Sabina; Lamy, Olivier; Senn, Christoph; Buffat, Helene; Perrelet, Romain; Hans, Didier; Lippuner, Kurt (2013). Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study. Journal of bone and mineral research, 28(3), pp. 449-454. Wiley-Blackwell 10.1002/jbmr.1775
Lippuner, K; Grifone, S; Schwenkglenks, M; Schwab, P; Popp, A W; Senn, C; Perrelet, Romain (2012). Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008. Osteoporosis international, 23(3), pp. 829-39. London: Springer-Verlag 10.1007/s00198-011-1660-8
Popp, Albrecht W; Windolf, Markus; Senn, Christoph; Tami, Andrea; Richards, R Geoff; Brianza, Stefano; Schiuma, Damiano (2012). Prediction of bone strength at the distal tibia by HR-pQCT and DXA. Bone, 50(1), pp. 296-300. New York, N.Y.: Elsevier 10.1016/j.bone.2011.10.033
Lippuner, K; Popp, A W; Schwab, P; Gitlin, M; Schaufler, T; Senn, C; Perrelet, Romain (2011). Fracture hospitalizations between years 2000 and 2007 in Switzerland: a trend analysis. Osteoporosis international, 22(9), pp. 2487-97. London: Springer-Verlag 10.1007/s00198-010-1487-8
Popp, A W; Senn, C; Franta, O; Krieg, M A; Perrelet, Romain; Lippuner, K (2009). Tibial or hip BMD predict clinical fracture risk equally well: results from a prospective study in 700 elderly Swiss women. Osteoporosis international, 20(8), pp. 1393-9. London: Springer-Verlag 10.1007/s00198-008-0808-7
Popp, Albrecht W E; Bodmer, Christine; Senn, Christoph; Fuchs, Gaby; Kraenzlin, Marius E; Wyss, H; Birkhaeuser, Martin H; Lippuner, Kurt (2006). Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy. Maturitas, 53(2), pp. 191-200. Amsterdam: Elsevier 10.1016/j.maturitas.2005.04.004
